On June 2, 2021 JSC Olainfarm organized its Investor Conference Webinar. During the webinar Chairman of Management Board Jeroen Weites and Investor Relations Advisor Janis Dubrovskis analyzed the financial
Zane Kotane leaves her position as the Member of the Management Board of JSC Olainfarm
The Supervisory Council of JSC Olainfarm has received an application from the current member of the Management Board Zane Kotane to resign from May 19. I would like to thank Zane Kotane for her achievements in the development of JSC Olainfarm, improving financial and management processes, as well as contributing to the implementation of the company s strategy and promotion of sustainable growth. I wish her success in future professional challenges, emphasizes
Gundars Berzinš, Chairperson of the Supervisory Council of JSC Olainfarm.
The Chairperson of the Management Board Jeroen Weites and Members of the Management Board Elena Bushberg, Signe Baldere-Sildedze and Raimonds Terentjevs continue to fulfil their duties at the Management Board of JSC Olainfarm.
Olainfarm: Audited annual report 2020
The Company reviewed operations in the main markets
JSC Olainfarm continued investments to modernize its operations and worked on clinical trials
Group s revenues in 2020 were EUR 122,157 thousand, net profit was EUR 9,478 thousand.
Group actively engaged to improve operations and financial results of subsidiaries
In 2020, JSC Olainfarm approved its new strategy Forward! 2020-2025 . The main goal is to become one of the TOP 10 largest pharmaceutical manufacturing companies in Central and Eastern Europe by 2025, sustainably supplying healthcare products and services in specific therapeutic areas: cardiovascular diseases, neurology, psychiatry, and the treatment of urinary diseases. In 2020 Olainfarm Group continued the transformation process towards sustainable growth. Due to the Covid-19 pandemic, it was a year of challenges to remain operational efficient, where innovative ways of thinking to break the traditional way of conducting busin
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;